logo

For the Inventor, By the Inventor

Roslyn Heights, NY, United States of America

Robert Bittman

This inventor holds 16 USPTO granted patents. Top assignees: The City University of New York, The University of British Columbia, Children's Hospital Research Center at Oakland. Active years: 1993-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Bittman. Retrieved from https://idiyas.com/inventor/robert-bittman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 68.8

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Rosyln Heights, NY (US) (2003)
  • Roslyn Heights, NY (US) (1993 - 2016)

Company Filing History:

goldMedal7 out of 337 
 
The City University of New York
 patents
silverMedal3 out of 963 
 
The University of British Columbia
 patents
bronzeMedal2 out of 77 
 
Children's Hospital Research Center at Oakland
 patents
4. 1 out of 514 
 
Albert Einstein College of Medicine
 patents
5. 1 out of 1,810 
 
Mayo Foundation for Medical Education and Research
 patents
6. 1 out of 115 
 
The Liposome Company, Inc.
 patents
7. 1 out of 212 
 
University of Manitoba
 patents
8. 4 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2016

Loading Chart...
16 patents (USPTO):Explore Patents
1. 9359389 - Caged ceramide-1-phosphate derivatives (2016-06-07),
2. 9133097 - Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer (2015-09-15),
3. 8741967 - Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer (2014-06-03),
4. 8277775 - Boron dipyrromethene difluoro (BODIPY) conjugates (2012-10-02),
5. 8263576 - Non-natural sphingolipid analogs and uses thereof (2012-09-11),
6. 8153615 - Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds (2012-04-10),
7. 8030482 - Free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluorophore in the side chain and method of preparation and use thereof (2011-10-04),
8. 7323601 - Enanitomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics (2008-01-29),
9. 6613748 - C-glucosyl ether lipids (2003-09-02),
10. 6573246 - Modified ether glyceroglycolipids (2003-06-03),
11. 6153736 - Modified ether glyceroglycolipids (2000-11-28),
12. 5837732 - Antimycobacterial compounds and method of using same (1998-11-17),
13. 5756774 - Synthesis of myo-inositol phosphates (1998-05-26),
14. 5506217 - Phosphonates as anti-cancer agents (1996-04-09),
15. 5369097 - Phosphonates as anti-cancer agents (1994-11-29),

Title: The Innovative Journey of Robert Bittman

Introduction: Robert Bittman, a talented inventor hailing from Roslyn Heights, NY, has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Robert Bittman holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on cutting-edge advancements in renewable energy and sustainable materials.

Career Highlights: Throughout his illustrious career, Robert Bittman has been recognized for his groundbreaking inventions that have improved efficiency and sustainability in different industries. His work has revolutionized the way we approach challenges and has set new standards for innovation.

Collaborations: Robert Bittman has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible products that benefit society.

Conclusion: Robert Bittman's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations to push the boundaries of what is possible through creativity and ingenuity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…